Mirae Asset Global ETFs Holdings’s Stoke Therapeutics STOK Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio STOK Stock Details STOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.63M	Buy	80,522 +46,649	+138%	+$1.5M	﹤0.01%	1117
2026 Q1	$1.1M	Buy	33,873 +1,358	+4%	+$44.5K	﹤0.01%	1475
2025 Q4	$1.03M	Sell	32,515 -17,948	-36%	-$540K	﹤0.01%	1499
2025 Q3	$1.19M	Sell	50,463 -2,948	-6%	-$50.5K	﹤0.01%	1387
2025 Q2	$607K	Buy	53,411 +29,244	+121%	+$278K	﹤0.01%	1714
2025 Q1	$162K	Buy	24,167 +1,149	+5%	+$10.7K	﹤0.01%	2417
2024 Q4	$253K	Buy	23,018 +313	+1%	+$3.85K	﹤0.01%	2262
2024 Q3	$279K	Buy	22,705 +5,054	+29%	+$71.6K	﹤0.01%	2199
2024 Q2	$238K	Buy	+17,651	New	+$238K	﹤0.01%	2164

Other funds holding STOK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's STOK Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Stoke Therapeutics (STOK) stake by 138% in Q2 2026, buying an estimated $1.5M and bringing the position to 80,522 shares worth $2.63M. The position accounts for ﹤0.01% of the portfolio, ranked #1117.

Mirae Asset Global ETFs Holdings first reported a position in STOK in Q2 2024 and has held it in 9 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

Mirae Asset Global ETFs Holdings held 80,522 shares of Stoke Therapeutics worth $2.63M as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 46,649 Stoke Therapeutics shares in Q2 2026, an estimated $1.5M.
Stoke Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1117 holding.
Mirae Asset Global ETFs Holdings first reported a position in Stoke Therapeutics in Q2 2024 and has held it in 9 quarters since.
197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.